Jennifer Drimmer Rokovich is joining Tenaya Therapeutics as it seeks to bring to market gene therapy regimens to combat heart disease.
January 28, 2022 at 05:43 PM
2 minute read
Veteran biotech attorney Jennifer Drimmer Rokovich has come aboard as general counsel of Tenaya Therapeutics, a San Francisco-based company developing gene therapy regimens to combat heart disease.
Rokovich was previously senior vice president, corporate legal affairs and secretary at Exelixis, a publicly traded oncology-treatment company with a market value of $5.6 billion. Rokovich will report directly to Tenaya CEO Faraz Ali.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Predictive reporting, trend analysis, peer guidance and a practical playbook to help genetal counsels succeed in their increasingly high stakes roles as risk managers and corporate strategists
Jennifer Drimmer, general counsel of Tenaya Therapeutics. Courtesy photo
